Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
28.09
-0.05 (-0.18%)
At close: Apr 25, 2025, 4:00 PM
28.18
+0.09 (0.32%)
After-hours: Apr 25, 2025, 7:57 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 38.08, with a low estimate of 22 and a high estimate of 68. The average target predicts an increase of 35.56% from the current stock price of 28.09.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Hims & Hers Health stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 4 | 4 |
| Buy | 0 | 1 | 1 | 0 | 0 | 0 |
| Hold | 6 | 6 | 5 | 7 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 13 | 14 | 14 | 14 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Sell Maintains $27 → $25 | Strong Sell | Maintains | $27 → $25 | -11.00% | Apr 25, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $39 → $33 | Hold | Maintains | $39 → $33 | +17.48% | Apr 10, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $21 → $22 | Sell | Maintains | $21 → $22 | -21.68% | Mar 18, 2025 |
| B of A Securities | B of A Securities | Sell Reiterates $21 | Sell | Reiterates | $21 | -25.24% | Mar 6, 2025 |
| Citigroup | Citigroup | Strong Sell Reiterates $27 | Strong Sell | Reiterates | $27 | -3.88% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
2.37B
from 1.48B
Increased by 60.78%
Revenue Next Year
2.82B
from 2.37B
Increased by 18.96%
EPS This Year
0.63
from 0.53
Increased by 17.64%
EPS Next Year
0.91
from 0.63
Increased by 45.26%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.5B | 3.2B | 4.2B | ||
| Avg | 2.4B | 2.8B | 3.4B | ||
| Low | 2.2B | 2.2B | 2.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 69.8% | 33.8% | 47.0% | ||
| Avg | 60.8% | 19.0% | 21.1% | ||
| Low | 47.5% | -7.8% | 2.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.93 | 1.73 | 2.18 | ||
| Avg | 0.63 | 0.91 | 1.30 | ||
| Low | 0.21 | 0.28 | 0.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 75.6% | 176.7% | 140.1% | ||
| Avg | 17.6% | 45.3% | 42.7% | ||
| Low | -61.3% | -54.6% | -1.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.